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Cellular/Molecular
Dihydropyridine Receptors and Type 1 Ryanodine Receptors
Constitute the Molecular Machinery for Voltage-Induced
Ca2 Release in Nerve Terminals
Vale´rie De Crescenzo,1 Kevin E. Fogarty,1,3 Ronghua ZhuGe,1,3 Richard A. Tuft,1,3 Lawrence M. Lifshitz,1,3
Jeffrey Carmichael,3 Karl D. Bellve´,1,3 Stephen P. Baker,2 S. Zissimopoulos,4 F. Anthony Lai,4 Jose´ R. Lemos,1 and
John V. Walsh Jr1
1Department of Physiology and 2Information Services Bioinformatics Unit, University of Massachusetts Medical School, Worcester, Massachusetts 01655,
3Biomedical Imaging Group, University of Massachusetts Medical School, Worcester, Massachusetts 01605, and 4Wales Heart Research Institute, Cardiff
University, Cardiff CF14 4XN, United Kingdom
Ca2 stores were studied in a preparation of freshly dissociated terminals from hypothalamic magnocellular neurons. Depolarization
fromaholding level of80mVin theabsenceof extracellularCa2 elicitedCa2 release from intraterminal stores, a ryanodine-sensitive
process designated as voltage-induced Ca2 release (VICaR). The release took one of two forms: an increase in the frequency but not the
quantal size of Ca2 syntillas, which are brief, focal Ca2 transients, or an increase in global [Ca2]. The present study provides evidence
that the sensors of membrane potential for VICaR are dihydropyridine receptors (DHPRs). First, over the range of80 to60 mV, in
which there was no detectable voltage-gated inward Ca2 current, syntilla frequency was increased e-fold per 8.4 mV of depolarization,
a value consistent with the voltage sensitivity of DHPR-mediated VICaR in skeletal muscle. Second, VICaR was blocked by the dihydro-
pyridine antagonist nifedipine, which immobilizes the gating charge of DHPRs but not by Cd2 or FPL 64176 (methyl 2,5 dimethyl-4[2-
(phenylmethyl)benzoyl]-1H-pyrrole-3-carboxylate), a non-dihydropyridine agonist specific for L-type Ca2 channels, having no effect
on gating charge movement. At 0 mV, the IC50 for nifedipine blockade of VICaR in the form of syntillas was 214 nM in the absence of
extracellular Ca2. Third, type 1 ryanodine receptors, the type to which DHPRs are coupled in skeletal muscle, were detected immuno-
histochemically at the plasma membrane of the terminals. VICaR may constitute a new link between neuronal activity, as signaled by
depolarization, and a rise in intraterminal Ca2.
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Introduction
In common with virtually every cell type, neurons contain intra-
cellular Ca2 stores from which Ca2 can be discharged into the
cytosol through intracellular Ca2 release channels. Although
there has been considerable interest in Ca2 stores located
postsynaptically, those in nerve terminals have received scant
attention until recently (Berridge, 1998; Melamed-Book et al.,
1999; Llano et al., 2000; Suzuki et al., 2000; Emptage et al., 2001;
Sharma and Vijayaraghavan, 2003). Now it has become clear that
Ca2 stores in nerve terminals are involved in physiological pro-
cesses such as long-term potentiation (Lauri et al., 2003) and
long-term depression (Unni et al., 2004) as well as pathophysio-
logical states such as spinal cord injury (Ouardouz et al., 2003).
The mechanisms for mobilizing Ca2 from stores is not known
in many cases, and it is often simply assumed that calcium-
inducedCa2 release (CICR) arising fromCa2 influx is respon-
sible or that CICR is the sole mobilizing mechanism for
ryanodine-sensitive stores in neurons (Bouchard et al., 2003;
Collin et al., 2005).
Recently, we demonstrated short-lived focal Ca2 transients
mediated by the class of Ca2 release channels known as ryano-
dine receptors (RyRs) in freshly dissociated magnocellular nerve
terminals (De Crescenzo et al., 2004). These neurohypophyseal
terminals are a favorable preparation because they are relatively
large and are isolated without an accompanying postsynaptic
structure (Lemos and Nowycky, 1989; Neher, 1998). Because
these Ca2 transients closely resemble Ca2 sparks in muscle, in
both their time course and quantity of Ca2 released, they were
designated Ca2 syntillas [scintilla (Latin for “spark”) in a nerve
terminal, typically a synaptic structure]. Using whole-cell, tight-
seal voltage clamp, we also demonstrated for the first time that
depolarization in the absence of extracellular Ca2 either in-
creased syntilla frequency or caused an increase in global [Ca2].
This process, which had not been observed previously in any cell
type other than muscle, we designate as voltage-induced Ca2
release (VICaR). We now ask which proteins provide the voltage
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sensors in the plasma membrane for VICaR and which serve to
release the Ca2 from the stores into the cytosol. That is, what are
the sensors and effectors for VICaR? In our previous study, we
showed that both spontaneous syntillas and VICaR were ryano-
dine sensitive, indicating that RyRs serve at least as one of the
effectors of VICaR.
Here we provide evidence that the voltage sensors for VICaR
in the plasma membrane in terminals of hypothalamic neurons
are dihydropyridine receptors (DHPRs). Moreover, it appears
that the DHPRs are linked to type 1 RyRs in a manner bearing
similarities to the mechanism in skeletal muscle. Comparison
with another excitatory secretory cell, the chromaffin cell, sug-
gests that VICaRdemands the presence of type 1 RyRs. This study
provides us with information about the molecular machinery of
VICaR in neurons, a process that may constitute a new link be-
tween neuronal activity, as signaled by depolarization of the
plasma membrane, and a rise in Ca2 in nerve terminals.
Materials andMethods
Electrophysiology and calcium imaging. Isolated nerve terminals from
adult Swiss Webster mouse hypothalamic neurons were patched in
“whole-terminal” configuration (De Crescenzo et al., 2004). Pipette so-
lution contained the following (inmM): 0.05K5fluo-3 (Invitrogen, Carls-
bad, CA), 135 KCl, 2 MgCl2, 30 HEPES, 4 MgATP, and 0.3 Na-GTP, pH
7.2. Ca2-free bath solution contained the following (in mM): 135 NaCl,
5 KCl, 10 HEPES, 10 glucose, 0.2 EGTA, and 1 MgCl2, pH 7.2. For
Ca 2-containing bath solution, calcium was added (2.2 mM) and
EGTA was omitted. Nifedipine, cadmium, and FPL 64176 (methyl 2,5
dimethyl-4[2-(phenylmethyl)benzoyl]-1H-pyrrole-3-carboxylate)
(FPL) (from Sigma, St. Louis, MO) were applied by a puffer pipette for
4–8 min before recording commenced. Fluorescence images using
fluo-3 as a calcium indicator were obtained using a custom-built wide-
field, high-speed digital imaging system described in detail previously
(ZhuGe et al., 1999; De Crescenzo et al., 2004). The terminals were im-
aged using a Nikon (Tokyo, Japan) 100, 1.3 numerical aperture (NA)
oil immersion lens, giving a pixel size of 133 nm at the specimen, with a
shutter to control exposure duration. Rapid imaging at 50 Hz (exposure,
10ms) was performed for 4 s at a time. Twomeasures of Ca2were used:
one to quantify the total amount of Ca2 released per syntilla as deter-
mined by its “signal mass” (Sun et al., 1998; ZhuGe et al., 2000), and
another, F/F0, to assess mean increase in global [Ca
2].
Immunocytochemistry. Axon terminals, isolated as described above
and plated onto poly-L-lysine-coated coverslips were fixed and perme-
abilized (0.1 M ethanolamine in PBS plus 0.1% Triton X-100, pH 8) and
then immunolabeled as described previously (De Crescenzo et al., 2004).
Polyclonal rabbit antibodies (Abs) for RyRs were generated using the
following epitopes: RREGPRGPHLVGPSRC for RyR1 (Mitchell et al.,
2003) and KAALDFSDAREKKKPKKDSSLSAV for RyR2 (Tunwell et al.,
1996). These sequences are unique to RyR1 and RyR2, respectively, in
rabbit, human, and mouse (see Fig. 7). For these antisera, preimmune
rabbit serum was used as a control. The polyclonal rabbit anti-RyR3
antibody was developed against purified glutathione S-transferase fusion
protein corresponding to the region of low homology between the trans-
membrane domains 4 and 5 of RyR3 and run through an affinity-
purification column (Giannini et al., 1995). For the N-type channel,
affinity-purified goat antibody was used (CP -1B; Santa Cruz Biotech-
nology, Santa Cruz, CA). For the latter two polyclonals, purified IgG
(Jackson ImmunoResearch, West Grove, PA) was used as control (see
Fig. 6). The antibodies for the three RyRs are the same ones used in a
previous study on mouse chromaffin cells (ZhuGe et al., 2006). Because
the RyR1 antiserum is critical for this study, we confirmed its specificity
with a Western blot performed as described previously (Zissimopoulos
and Lai, 2005). For each immunocytochemical preparation, neurohy-
pophyseal terminals from six mice were pooled together. Three prepara-
tions were made for imaging RyR1 and an additional two for RyR2 and
RyR3, each with its own control. Hundreds of stained terminals were
viewed in each preparation, and the results, as shown in Figure 6, are
Figure 1. Method of correcting for nonspecific immunofluorescence. Diagrams and data in
this figure are all for the immunofluorescence caused by preimmune serum (i.e., controls),
which were used for corrections. A, Left, Diagrammatic representation of the concentric shells
attributable to preimmune immunofluorescence for which intensity histograms were con-
structed. Top right, Stack of intensity histograms for all of the voxels (green in diagram at left)
was constructed for each distance (d) from the surface of the cell. For each distance, intensity
histograms from several (n 7) control terminals were combined to yield a single average
histogram. B. Top, Intensity histogram for the shell at a distance of 0.3m from the surface as
an example. We took the 95th percentile of brightness from the preimmune control average at
each shell (example is shown for 0.3mwith dashed blue line), and we plotted it versus the
distance from the surface of the terminal. This curvewas then used to correct all data of the type
shown in Figure 6A.
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representative of images fully analyzed (as explained in Fig. 1) from 15
typical terminals. Another preparation was used with double staining for
either RyR1 and N-type channels or RyR2 and N-type channels. The
results from these experiments, as shown in Figure 7, derived from fully
analyzed images typical of hundreds observed.
Three-dimensional fluorescence imaging was performed on an in-
verted wide-field microscope (Nikon Diaphot 200) with excitation by a
100 W mercury lamp. Images were obtained through a 60, 1.4 NA oil
immersion Plan Apo objective (Nikon) and digitally recorded on a
cooled, back-thinned CDD camera (PhotoMetrics, Tucson, AZ) with an
effective pixel size at the specimen of 83 nm in x–y and a z spacing of 250
nm. This resulted in a three-dimensional stack of 25 image planes of
each terminal. Stacks were processed to remove out-of-focus fluores-
cence and enhanced axial resolution using custom-constrained, iterative
deconvolution software (Carrington et al., 1995; Scriven et al., 2005).
From those optical sections, we built a three-dimensional reconstruction
of the immunostained nerve terminal.
The fluorescence from the preimmune serum control was not uni-
form, being especially bright near the plasma membrane. Hence, we
determined the brightness of concentric shells in the control images (i.e.,
those attributable to immunolabeling of preimmune serum) from the
edge of the terminal to the inside, as illustrated in the diagram in Figure
1A, and we did this for both preimmune controls and the immunola-
beled terminal. Each shell then has its own average control intensity with
preimmune serum.We take the 95th percentile of brightness from those
preimmune control averages (at each shell) and plot them versus the
distance from the plasma membrane. The curve obtained is represented
in Figure 1B and was used to correct the data.
Data analysis. In all cases, data are reported as mean SEM; n is the
number of syntillas, and N the number of observations, which in most
cases is the same as the number of terminals. The specific statistical tests
used are found in the supplemental methods (available at www.
jneurosci.org as supplemental material), and p  0.05 was considered
significant. Constrained nonlinear regression from SPSS (2003 version)
was used to fit the data of Figure 2C with an expression of the form
Ce (V /k )  FB, with C being a constant with units of frequency. This
expression arises from a modification of a Boltzmann distribution (sup-
plemental data, available at www.jneurosci.org as supplemental mate-
rial): FV  A Ps(Vo) e
(V /k )  FB, where Ps(V) is very small. Here FV is
syntilla frequency at a given membrane potential V; FB is basal syntilla
frequency, which is independent of membrane potential; Ps(V) is the
probability of the voltage sensor being in a state in which it can trigger a
syntilla at a given voltage V; Vo is the value of V at which Ps(V) is 0.5; k is
a slope factor; e is the base of the natural logarithm; and A is a propor-
tionality constant. We note that FB is independent of the voltage sensor.
Results
VICaR in the form of Ca2 syntillas exhibits the magnitude of
voltage dependence expected for a DHPR
Syntilla frequency increased when the membrane potential was
jumped from80 to60mV (Fig. 2A,B). This was true not only
in the presence of extracellular Ca2 but also in its absence, and
the magnitude of the effect was the same under both conditions
(supplemental Fig. 1, available at www.jneurosci.org as supple-
mental material) (De Crescenzo et al., 2004). Moreover, even in
the presence of extracellular Ca2, no increase in global [Ca2]
was found during depolarization over the voltage range from
80 to 60 mV. Finally, low-voltage-activated Ca2 channels
(i.e., T-type channels) are not found in these hypothalamic nerve
terminals in rat, although every othermajor class of voltage-gated
Ca2 channel is present (Wang et al., 1997, 1999). For all these
reasons, the increase in syntilla frequency cannot be attributed to
Ca2 influx and subsequent CICR. Because the increase was also
seen in the presence of extracellular Ca2 over this range of
potentials, a mechanism involving Na influx through Ca2
channels cannot be invoked. The absence of Na involvement is
supported by the fact that current–voltage plots of the voltage-
Figure 2. Syntillas are increased in frequency by membrane depolarization. A, Representative
imagesof syntillas (not successive frames)whenmembranepotential isheldat80mV(toprow)or
after it is jumped from80 to60mV (bottom row) in the presence of extracellular Ca 2. B, As
shownfor80and60mV,syntilla frequencydata(bargraphs)arewell fitbyPoissondistributions
(open circles connected by line) ( p 0.98 and 0.675, respectively, Kolmogorov–Smirnov test). The
distributionsdifferwithmeansof1.38(n47)and2.52(n58)syntillasper2.5ssamplinginterval
( p 0.023) for80 and60mV, respectively. C, Top shows the voltage dependence of syntilla
frequency and is characterized by the fitted expression (red line) derived from the following: A Ps(Vo)
e (V/k) FB (as defined inMaterials andMethods). k is found to be 8.40mV,with a 95% confidence
level that this value lies between7.83and8.98mV (seeMaterials andMethods), and FB, is 0.41 s
1.
Bottomshows that theaveragenumberof Ca ions releasedper syntilla (which isdirectlyproportional
tothesignalmass)doesnotchangeasafunctionofmembranepotential.D,Timecourseofchanges in
syntilla frequency calculated every 1.3 s to increase temporal resolution. Fluorescence is recorded in
eachof 18nerve terminals four times in a row for 4 s, separatedby2min, the latter indicatedbygaps
in the plots. In the first and third recordings, nerve terminals are depolarized to70 and60mV
(filled circles), respectively, for 2.6 s and then repolarized to80 mV (open circles) for 1.3 s. In the
second and fourth recordings, they aremaintained at the holding potential of80mV for 4 s.
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activated Na current show no detectable
current at potentials below40 mV (data
not shown) (Wang et al., 1992). The same
sort of increase in frequency during depo-
larization over this range of potentials is
found for Ca2 sparks in amphibian skel-
etal muscle (Klein et al., 1996).
The number of syntillas per observa-
tion period was well fit by a discrete Pois-
son distribution at all potentials between
80 and 60 mV. Examples of such fits
are exemplified (Fig. 2B) for the two po-
tentials at the extremes of the range exam-
ined,80 and60 mV. This is consistent
with a view of syntillas as independent
events with a stochastic activation process
over this range of potentials, as seen for
sparks in skeletal muscle (Klein et al.,
1996). Moreover, as expected for such a
process, the percentage of observation pe-
riods in which there were failures, i.e., no
syntillas, decreased at60mV (Fig. 2B). It
was not possible to extend this sort of ob-
servation to more positive potentials be-
cause the increase in syntilla frequency
started to give way to global increases in
[Ca2] (see below).
The increase in frequency during depo-
larization (Fig. 2C) was well characterized
by an exponential function, given in the
legend to Figure 2C, with an e-fold in-
crease per 8.40mV of depolarization and a
basal frequency of 0.41 s1, which is inde-
pendent of voltage. In determining such a
fit, the basal frequency or asymptote in
Figure 2C is constrained by two experi-
mental facts. First, on a hyperpolarizing
jump from80 to95 mV, there was no
additional decrease in the syntilla rate
(data not shown). Second, when the
voltage-sensitive component is eliminated
by saturating concentrations of nifedipine
during depolarization to 0 mV (see below
and Fig. 4), the frequency is reduced to the
basal frequency at80 mV. For compari-
son, the voltage sensitivity at negative po-
tentials of DHPR-mediated release of
Ca2 from stores in amphibian skeletal
muscle as measured by gating charge
movement is 7.7  0.6 mV (Shirokova et al., 1995). This is in
general agreement with our results, which might be expected,
because it has been reported that the same DHPR  isoform
found in skeletal muscle (1S) is expressed in rat magnocellular
neurons (Mutsuga et al., 2004). Moreover, in skeletal muscle,
DHPRs serve as voltage sensors for VICaR by reason of voltage-
induced conformational changes that give rise to gating currents.
Such gating charge movements are detected in skeletal muscle
over the negative range of potentials shown in Figure 2, which are
below the threshold for Ca2 current through the small fraction
of DHPRs that conduct Ca2 in skeletal fibers (Schwartz et al.,
1985). These qualitative and quantitative similarities between
VICaR in nerve terminals and in skeletal muscle suggest that
dihydropyridine-sensitive membrane proteins function as volt-
age sensors in both cases.
Finally, the time course of VICaR is of importance in deter-
mining themechanism at work. Figure 2D shows the time course
of alteration in syntilla frequency during depolarization and sub-
sequent repolarization. The change during a shift in potential
occurs on a subsecond timescale. In addition to the well recog-
nized mechanism of VICaR in skeletal muscle, there is some ev-
idence that DHPRs can be coupled to G-proteins, for example in
cultured skeletal myocytes, and act via a second messenger. The
time course of this effect is quite slow, however, on the order of
tens of seconds after tetanic stimulation (Araya et al., 2003). The
rapid onset of VICaR and its rapid termination in Figure 2D do
Figure3. Effects of nifedipine onVICaR in the absence andpresence of extracellular Ca 2.A, The effect of 500nMnifedipine on
VICaR in the absence of extracellular Ca 2 with 200M EGTA added to the extracellular solution. Each row of images is taken
before (first image in each row) the jump inmembrane potential from80 to 0mV and at various times during 1800ms at 0mV
(remaining images). Top two rows show images in the absence of extracellular Ca 2 (with 200M EGTA) under control condi-
tions (first row) and after exposure to 500 nM nifedipine (second row). Rows three and four are the same but in the presence of 2.2
mM Ca 2with 200M Cd 2without EGTA. B, Traces on the left show time course ofF/F0 (mean SE) during depolarization
from80 to 0 mV in Ca 2-free solution in the absence (black; n 14) and presence (blue; n 16) of nifedipine.F/F0 is
calculated from the fluorescence intensitymeasured in thewhole nerve terminal for each image taken every 20ms. The red arrow
indicates the timewhen the potential is jumped to 0mV,whichwas 200ms after the beginning of the recording. The traces on the
right show the effect of nifedipine (500 nM) on VICaR in the presence of normal extracellular Ca 2with 200M Cd 2 present to
block Ca 2 influx (n 14 and 29, without and with nifedipine) using the same conventions and experimental paradigm as the
traces on the left. The averageF/F0 taken over the final 0.5 s of the traces is decreased in the absence of Ca
2 (left) from0.78
0.24 to 0.10 0.03 (n 14 and 16, respectively; p 0.016) and in the presence of Ca 2 and Cd 2 (right) from 1.34 0.49
to 0.21 0.09 (n 14 and 29, respectively; p 0.0004.).
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not appear consistent with this sort of G-protein-mediated effect
(see Discussion).
Whereas the frequency of syntillas increased with depolariza-
tion (Fig. 2C, top), the mean number of Ca ions released per
syntilla, which is directly proportional to the peak signal mass,
was not altered by depolarization (Fig. 2C, bottom). In addition,
the mean number of Ca ions per syntilla was not affected by the
presence or absence of extracellular Ca2 (De Crescenzo et al.,
2004). Hence, over this range of potentials, the syntilla functions
as a quantal release of Ca2 whose frequency is increased by
depolarization independently of Ca2 influx.
The dihydropyridine antagonist nifedipine blocks VICaR
Nifedipine acts on DHPRs by immobilizing their gating charge,
thus serving as an “antagonist” of those DHPRs that conduct
Ca2, i.e., L-type Ca2 channels. This action also makes nifedi-
pine an excellent and well studied uncoupler of excitation from
contraction in skeletal muscle, in which the movement of the
charge-bearing DHPR “gate” by depolarization appears to pro-
vide the mechanical displacement to interact with the RyR. The
interaction is assumed to be allosteric; that is, the voltage sensors
act at a contact site on the release channel and thereby alter the
properties of the RyR protomers, leading to their cooperative
opening or closing (Rios and Brum, 1987; Rios et al., 1993;
Proenza et al., 2002). Because nifedipine, like other dihydropyri-
dines, is more effective at less negative potentials, we first exam-
ined its effects at 0 mV (Bean, 1984). The responses to a depolar-
ization from 80 to 0 mV (Fig. 3) took the form of either an
increase in syntilla frequency or an increase in global [Ca2]. The
latter, which occurred 43%of the time, is illustrated by the images
of Figure 3A. The time derivative of the global increase provides
an index of net Ca2 influx into the cytosol and is shown in
supplemental Figure 2 (available at www.jneurosci.org as supple-
mental material). An early rapid net influx is evident, followed by
a later, slower phase, and the response closely follows the time
course of the stimulus (see Discussion). In the remaining cases,
the terminals responded to depolarization with an increase in
syntilla frequency. To examine the effects of nifedipine, we
grouped all responses, both syntillas and increases in global
[Ca2], and used the traditional measure, F/F0, an index of
cytosolic Ca2 concentration, tomeasure theCa2 released from
stores (Fig. 3B). In the absence of extracellular Ca2 (200 M
EGTA added), nifedipine (500 nM) greatly decreased the release
of Ca2 from stores (Fig. 3A) (supplemental Fig. 2, available at
www.jneurosci.org as supplemental material). The time deriva-
tive of these traces, shown in supplemental Figure 2 (available at
www.jneurosci.org as supplemental material), discloses an early
rapid net influx followed by a later, slower phase; both are atten-
uated by nifedipine. With normal extracellular [Ca2] but in the
presence of Cd2 to block Ca2 influx (Fig. 3B) (supplemental
Fig. 2, available at www.jneurosci.org as supplemental material),
the effect of nifedipine was the same.
We also examined the effects of nifedipine at 0 mV in those
instances in which depolarization caused only an increase in syn-
tilla frequency. We first note that the mean amount of Ca2
released per syntilla was not significantly different at 80 and 0
mV ( p 0.35, Mann–Whitney test; n 28 and 48, respectively)
(Fig. 4, bottom, filled bars). Hence, the quantum of Ca2 repre-
sented by syntillas elicited at 0 mV was similar to that of the
syntillas over the negative range of potentials in Figure 2. Nifed-
ipine blocked the voltage-dependent increase in syntilla fre-
quency (Fig. 4). The IC50 was smaller when we examined the
syntilla frequency in the final two-thirds of the 3.6 s observation
period at 0mV (inset at top right). This is to be expected given the
use dependence of the dihydropyridines (Bean, 1984). At the
highest concentrations of nifedipine, the frequency was reduced
to approximately the same level as the spontaneous rate observed
at80 mV (filled circle) and designated as FB in the formulation
given in the legend. This is consistent with the identification of FB
as a frequency independent of the voltage sensor, resulting from
independent, “spontaneous” activity of the effector (i.e., RyR) or
from a population of effectors not under the control of the sen-
sor. In terms of themodified Boltzmann expression in the legend
for Figure 2,FB is the limiting value ofFV at very negative voltages.
Also consistent with this interpretation, hyperpolarizing steps
from80 to95 mV in the presence of extracellular Ca2 pro-
duced no detectable change in syntilla frequency (data not
shown).
The amount of Ca2 released per syntilla did not decrease
even in the presence of the highest concentration of nifedipine,
consistent with an action on a voltage sensor that governs syntilla
frequency but not quantal size. The data in Figures 4 and supple-
mental Figure 2 (available at www.jneurosci.org as supplemental
material) reflect the fact that nifedipine acted by decreasing the
percentage of terminals that responded with a global increase in
Figure 4. Effect of nifedipine concentration on Ca 2 syntillas. Top, Ca 2syntilla frequency
recorded in nerve terminals depolarized to 0 mV for 3.6 s in the absence of extracellular Ca 2
with various doses of nifedipine (open triangles). n 19, 12, 7, 9, and 11 for 0.1, 0.5, 1, 5, and
10M nifedipine, respectively. Filled triangle represents syntilla frequency in the absence of
nifedipine after depolarization to 0 mV (n 7); filled circle is the frequency in the absence of
nifedipine at holding potential80 mV (n 8). Inset is the data only for the last 2.4 s of the
3.6 s period of depolarization. Bottom, The average number of Ca ions released per syntilla was
the same at80mV (n 28) and 0mV (n 48) in the absence of nifedipine (filled bars; p
0.35) and at 0 mV at the highest concentration (10M) of nifedipine (open bar; n 17; p
0.9). (For this analysis only, those terminals responding to depolarization with an increase in
syntilla frequencywere included,making it likely that the IC50 of nifedipine is overestimated, on
the assumption that the terminals that yielded a global increase did so in part because their
syntilla frequency was higher.)
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[Ca2], by decreasing the magnitude of
that global increase and by decreasing syn-
tilla frequency in those terminals that did
not respond with an increase in global
[Ca2].
FPL does not affect VICaR
Because nifedipine exerted its action in the
absence of extracellular Ca2 or in the
presence of Cd2when extracellular Ca2
was included, its action cannot be a result
of preventing Ca2 entry. An additional
test of this was provided by the use of the
L-type Ca2 channel agonist FPL. FPL is a
Ca2 channel agonist that acts on a site
distinct from the DHPR binding site.
Moreover, FPL appears to act by prolong-
ing the open state of the channel with no
effect on the frequency of opening, which
is regulated by the movement of the
charged gate (McDonough et al., 2005). Thus, FPL provides an
important control in two respects: as a check on the possible
importance of Ca2 influx and as a test of the idea that the gating
chargemovementmust be affected to alter VICaR.We found that
FPL increased the voltage-activated current maximally at a po-
tential of approximately40mV in the terminals under the con-
ditions we use (5.8-fold increase; data not shown). Hence, we
assessed the action of FPL on VICaR with depolarization to40
mV in the absence of extracellular Ca2 (Fig. 5). FPL (2 M) had
no significant effect, whereas nifedipine (500 nM) blocked
VICaR. As was the case at 0 mV, nifedipine exerted its action by
decreasing the fraction of terminals that responded with a global
increase in [Ca2], decreased the magnitude of that increase,
and, in those terminals that responded with a decrease in syntilla
frequency, decreased the frequency of syntillas without altering
the number of Ca ions per syntilla. The number of Ca ions per
syntilla at 40 mV was not significantly different from what it
was at 80 mV. Thus, at this potential, as at 0 mV, the syntillas
continue to function as quanta of Ca2.
Type 1 RyRs are found close to the plasma membrane
If the DHPR is the voltage sensor for VICaR as it is in skeletal
muscle, then it is not unreasonable to think it might pair with
type 1 RyRs as it does in skeletal muscle (Beam and Franzini-
Armstrong, 1997). Hence, we would expect to find type 1 RyRs in
the nerve terminals, adjacent to the plasma membrane in which
they could interact withDHPRs. In previouswork (DeCrescenzo
et al., 2004), we have shown that ryanodine at blocking concen-
trations for theRyRdecreases syntilla frequency,whereas at lower
concentrations, it increases syntilla frequency. Caffeine also in-
creased syntilla frequency, whereas heparin was without effect. In
that study, no reliableAb forRyR1was available to us, but herewe
report results with Abs specific for type 1 and another specific for
type 2.
Immunocytochemistry (Fig. 6) showed that RyR1, RyR2, and
RyR3 receptors are found in images of the terminals, but their
distribution patterns are different. Only immunofluorescence
that was brighter than 95% of the control (i.e., preimmune se-
rum) brightness was counted [51% of corrected pixels for type 1
and 19% for type 2 remained after thresholding, implying that the
data were significantly different from controls (5%)]. We con-
sider type 1 RyRs first. Fluorescence caused by type 1 is bright
close to the surface of the terminal as is apparent in both the
uncorrected optical sections (Fig. 6A, left) and the same sections
corrected for fluorescence caused by preimmune serum (Fig. 6A,
right). Because the fluorescence caused by the preimmune serum
is brighter near the surface, the correction leads to a dimmer
signal in this region. Nonetheless, the RyR1 immunofluorescence
remains prominent near the surface in the corrected data. Nei-
ther type 2 nor type 3 follow this pattern. Type 2 is prominent in
the interior but essentially absent from the area near the surface as
indicated by the dark halo beneath the surface present in the
uncorrected images. This halo becomes even more obvious after
correction (Fig. 6A). Type 3 is not volume filling and found in a
restricted area well inside the nerve terminals and also at times in
Figure 5. FPL does not increase VICaR. A, AverageF/F0 traces in absence of external calcium, when nerve terminals were
depolarized from80 to40 mV (at the red arrow) for 1800 ms. The same paradigm, measurement, and conventions used in
Figure 2 are used here. FPL (red trace) had no significant effect, whereas 500 nM nifedipine (blue trace) decreased the average
F/F0 trace. B, Correspondingly, the time derivative of F/F0 was decreased by nifedipine but was not altered by FPL. C, Bar
graphs represent the averageF/F0 over the last second of the traces (50 images) shown in A. FPL at 2M did not significantly
( p 0.80) increaseF/F0, whereas nifedipine significantly (*p 0.05) decreasedF/F0 (n 33,48, and 21, for control, FPL,
and nifedipine, respectively).
Figure 6. Distribution of types 1, 2, and 3 RyRs. A, Representative immunofluorescent im-
ages from control (preimmune serum) and types 1 and 2 RyRs. B, Representative immunoflu-
orescent images from control (purified IgG) and type 3 RyR. For both A and B, each panel is an
optical section (0.65 m thick) through the middle z plane of the stack of images for the
terminal. The left column shows the deconvolved images; the tracing around the perimeter of
the terminal was drawn by eye on these images. The right column shows the corresponding
images after correction as outlined in Materials and Methods and Figure 1.
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a clump in one corner of the terminal (Fig. 6B) and at times in a
strand leading out of the terminal. (Possibly this strand is type 3
localized to an axonal remnant but additional investigation of
this localization is needed.) From these images, type 1 appears to
be the best candidate for VICaR.
To confirm these results, we did a second set of experiments in
which immunofluorescence of N-type channels was used to pro-
vide a marker of the plasma membrane. Figure 7A shows the
results of this set of experiments. From the typical corrected re-
constructions in the top of A and the averaged plot derived from
the bottom ofA, the relationship of each ryanodine receptor type
to the Ca2 channels and hence the plasmamembrane is clear. It
is apparent that type 1 RyRs are found as close to the cell surface
as the N-type channels within the limits of our resolution. This is
the sort of pattern to be expected if the RyR1 is coupled to a
voltage sensor in the plasma membrane. We note that immuno-
fluorescence caused by RyR1 and RyR2 and theN-type channel is
found in the interior of the terminal. In immuno-EM studies on
these terminals, N-type channels have been found on the dense-
core vesicles in the interior (Fisher et al., 2000) (also see Discus-
sion). In contrast to type 1, type 2 RyR density is lower in the
shells that are within a few hundred nanometers of the plasma
membrane. Figure 7B shows that the peptide used to produce the
anti-RyR1 is conserved between species (rabbit and mouse) but
poorly conserved in types 2 and 3. The Western blot in the bot-
tomof the Figure 7B demonstrate that the antibody recognizes an
RyR only in skeletal muscle preparation [lane 2, muscle homog-
enate; lane 4, sarcoplasmic reticulum (SR) membranes] and not
in cardiac preparation (lane 1, homogenate; lane 3, SR mem-
branes), confirming its specificity for type 1 RyR.
Moreover, this conclusion is supported by recent work on
chromaffin cells in which we found syntillas also mediated by
RyRs and almost identical in their properties to the ones studied
here. However, in chromaffin cells, there was no evidence for
VICaR and there were no type 1 RyRs (ZhuGe et al., 2006).
Discussion
How are DHPRs coupled to internal stores in
nerve terminals?
Three lines of evidence indicate that DHPRs are the sensors of
membrane potential involved in VICaR. First, the steepness of
the voltage dependence of Ca2 release at negative potentials is
compatible with what is expected for a skeletal muscle DHPR
(Klein et al., 1996). Second, nifedipine, which immobilizes the
gating charge movement in DHPRs, prevents VICaR, whereas
the Ca2 channel pore blocker Cd2 is without effect. Third, the
Ca2 channel agonist FPL, which does not act at the same site as
the dihydropyridines and does not appear to act on the gating
charge (McDonough et al., 2005), does not alter VICaR. Hence,
we can conclude that the DHPRs do not function in their role as
voltage-sensitive L-type Ca2 channels to allow Ca2 entry and
Figure 7. Distribution of type 1 RyR. A, Top, Images show two typical three-dimensional
nerve terminal reconstructions approximately3min thickness. In each image, distribution
of N-type Ca 2 channels is shown in red; the outer extent of this distribution serves as an
unambiguous marker for the plasma membrane. In the left image, green label marks type 1
RyRs, and, in the right image, blue label marks type 2 RyRs. Bottom, The graph provides the
average distribution of immunofluorescence for type 1 (green; n 4) and type 2 (blue; n 3)
RyRs and N-type Ca 2 channels (red; n 7) in concentric shells from the surface. (The yellow
arrows in the images above indicate the direction that the shells are layeredwith respect to the
surface, i.e., normal to it.) The graphs have been corrected for nonspecific fluorescence in each
shell using preimmune serum with the techniques outlined in Materials and Methods and
Figure 1. The RyR1s are located close to the surface. B, Top, Peptide sequence from which
4
anti-RyR1 was generated. The 15 amino acid sequence common to rabbit (R) and mouse (m)
was used to generate the antisera for RyR1. For comparison, the homologous sequence for
mouseRyR2andmouseRyR3are shownwith commonaminoacids in red. Bottom, Immunoblot
analysis of cardiac (card) and skeletal (ske) muscle crude homogenate (hom) and SR vesicle
preparations using the RyR1 epitope-specific antisera (1:1000 dilution) after SDS-PAGE and
protein electrophoretic transfer to polyvinylidene fluoride membrane. For both homogenate
lanes, 50g of protein was loaded, whereas for the SR lanes, 50 or 5g of protein was loaded
for cardiac and skeletal SR, respectively. The major, high-molecular-weight immunoreactive
banddetected only in the skeletalmuscle homogenate and SR vesicle lanes by theRyR1-specific
antisera corresponds in mobility to that of the purified skeletal muscle ryanodine receptor.
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trigger release from stores via CICR. Moreover, entry of Na ions
through Ca2 channels does not appear to be part of the mech-
anism because VICaR is observed (1) under conditions in which
Ca2 concentration is normal but Ca2 channels are blocked by
Cd2, and (2) at subthreshold levels for Ca2 channel activation
in either the absence or presence of extracellular Ca2.
What is themechanismof coupling betweenDHPRs andRyRs
in the nerve terminals studied here? Several lines of evidence
suggest that it is similar to the well documented interaction be-
tween DHPRs and type 1 RyRs underlying excitation–contrac-
tion in skeletal muscle. First, the molecular machinery for such
coupling is present in these terminals. Patch-clamp studies re-
vealed L-type Ca2 channels in the terminals (Lemos and Now-
ycky, 1989; Wang et al., 1997, 1999), and cDNA microarrays
studies have shown (Mutsuga et al., 2004) that magnocellular
neurons in rat express the same DHPR isoform (1S) coupled to
type 1 RyRs in skeletal muscle (Coronado et al., 2004). In neu-
rons, L-type calcium channels are almost always present but typ-
ically contribute only a minor fraction of the overall high-
threshold current (Bean and Mintz, 1994; Wang et al., 1997).
Indeed the L-type channels that couple to the type 1 RyRsmay be
nonconductive or poorly conductive (Schwartz et al., 1985) and
hence silent electrically unless one is recording gating currents
(Shirokova et al., 1995). Furthermore, as shown here, type 1 RyRs
are found immunocytochemically adjacent to the plasma mem-
brane in the terminals.
Although a direct coupling of this kind has heretofore been
established with clarity only in skeletal muscle, a direct link be-
tween RyRs andDHPRs has been suggested in neurons to explain
some of the axonal damage as a result of spinal cord injury
(Ouardouz et al., 2003). In that study, DHPRs and RyRs were
coimmunoprecipitated, which supports the idea of a direct phys-
ical interaction between them (Anderson, 1998), and such coim-
munoprecipitation (co-IP) had been seen previously in a rat
brain membrane preparation (Mouton et al., 2001). In both
co-IP studies, it was 1C that was precipitated with RyR1. How-
ever, co-IP experiments must be interpreted with care because
false positives are possible (Fletcher et al., 2003). Finally, RyRs
have been observed to interact functionally with DHPRs in ex-
cised membrane patches of cerebellar granule cells (Chavis et al.,
1996).
Another possible mechanism for VICaR involves DHPRs to
G-proteins as has been found in cultured skeletal myocytes
(Araya et al., 2003) and smoothmuscle cells (del Valle-Rodriguez
et al., 2003), but there is little quantitative data on the voltage
sensitivity of these DHPRs, so that comparison with our findings
is not possible. In the case of cultured skeletalmyocytes, the onset
of the increase in cytosolic [Ca2] induced by VICaR occurs tens
of seconds after tetanic stimulation, which ismuch different from
the time course in the nerve terminals (Figs. 1D, 2B, 4A,B) (sup-
plemental Fig. 2B, available at www.jneurosci.org as supplemen-
tal material). However, in the case of smooth muscle cells, the
time course is faster than the skeletal myocytes, but there is not
sufficient data on these cells to compare with the time course in
the nerve terminals (del Valle-Rodriguez et al., 2003). Finally, it
may be the case that DHPRs have as yet undiscovered properties
that are voltage activated, analogous to the recent discovery of
phosphatide phosphatase activity coupled to an intrinsic voltage
sensor (Murata et al., 2005). Whatever the precise mode of cou-
pling, it seems clear thatDHPRs are the voltage sensors forVICaR
in the nerve terminals studied here.
How general is VICaR in the nervous system?
Is VICaR confined simply to the terminals studied here or is it
found elsewhere? Quite often, the possibility of VICaR is not
considered for neurons and a CICR mechanism is simply as-
sumed, so there has been little exploration for VICaR. Moreover,
there appears to be considerable difficulty working in Ca2-free
solutions in some CNS tissue (Ransom and Brown, 2003). How-
ever, type 1 RyRs are found in many CNS neurons (Zupanc et
al., 1992; Giannini et al., 1995; Tarroni et al., 1997; Bouchard
et al., 2003), as are 1S DHPRs (Takahashi et al., 2003; Mut-
suga et al., 2004). So there is reason to suspect that VICaR is to
be found in many neuronal types. It would seem that CICR
should no longer simply be assumed as the mechanism when
ryanodine-sensitive Ca2 release is encountered in neurons.
Comparison with chromaffin cells
We reported recently that Ca2 syntillas are to be found in an-
other excitatory secretory cell, freshly dissociated mouse chro-
maffin cells (ZhuGe et al., 2006). Qualitatively, quantitatively,
and in their pharmacology, these syntillas resemble those found
in the neuron terminals studied here. However, these syntillas
were different in one important respect: their frequency was not
affected by depolarization in the absence of Ca2 influx, nor was
there any increase in global [Ca2] in response to depolarization.
That is, VICaR was absent. Both by reverse transcription-PCR
and by immunocytochemistry, type 1 RyRs were absent, whereas
type 2 RyRs and type 3 RyRs were present, type 2 in abundance.
Moreover, it appears that the skeletal muscle DHPR isoform
(1S) is not present in chromaffin cells (Baldelli et al., 2004).
Thus, it is tempting to postulate that the presence of type 1 RyRs
and/or the skeletal muscle DHPR isoform (1S) is a necessary
condition for VICaR. It is also noteworthy that there is no stain-
ing for RyR2 deep within the chromaffin cells, as we and others
(Fisher et al., 2000) have seen in the nerve terminals. It may be
that, in the terminals, which are far from the cell body, the dense-
core vesicles serve as stores for RyR2s and other proteins.
We may suggest an analogy between hypothalamic nerve ter-
minals and skeletal muscle on the one hand and chromaffin cells
and cardiac fibers on the other. In cardiac myocytes and chro-
maffin cells, RyR1 is missing and RyR2 is the dominant RyR
isoform. In these cell types, RyR2s are activated by Ca2 entry
from nearby voltage-gated channels via CICR. In contrast, in
skeletal muscle and hypothalamic nerve terminals, RyR1s are
found, as is VICaR; here alterations in membrane potential are
sufficient to release Ca2 from internal stores. In all of these cell
types, miniature Ca2 transients are found, sparks in all types of
muscle and Ca2 syntillas in neurons and chromaffin cells, all of
which are governed by VICaR or CICR depending on the cell
type.
What is the function of VICaR in neurons?
Clearly this mechanism is potentially a new and intriguing way to
couple neuronal activity to an increase in cytosolic Ca2 in nerve
terminals. This may allow for a release of Ca2 into a microdo-
main that is different from the exocytotic microdomain in which
it may have different, even diametrically opposed effects. An ex-
ample of such a differential effect is found in smooth muscle, in
which Ca2 sparks activate BK channels, causing relaxation,
whereas global increases in [Ca2] cause contraction (Nelson et
al., 1995; ZhuGe et al., 2006).
It is unclear as yet whether a single Ca2 syntilla can cause an
exocytotic event in nerve terminals. The evidence is in conflict at
this point. There is evidence that “maximinis” at the basket cell–
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Purkinje cell synapse in the cerebellum are caused by presynaptic,
focal Ca2 (Llano et al., 2000). There is also evidence that nico-
tine may cause Ca2 release from ryanodine-sensitive stores in
mossy fiber terminals, possibly by enhancing store filling, which
results in increased mini-frequency and increased quantal size
(Sharma and Vijayaraghavan, 2003). Although these intriguing
studies are convincing, they monitor exocytosis only postsynap-
tically and therefore indirectly. In contrast, in mouse chromaffin
cells (ZhuGe et al., 2006), a single syntilla did not trigger a spon-
taneous exocytotic event at resting potential as detected ampero-
metrically (Haller et al., 1998), nor did blocking virtually all syn-
tillas cause a change in frequency of spontaneous exocytotic
events. At least in some excitable exocytotic cells, it would seem that
syntillas do not trigger exocytosis, presumably because they do not
occur in the appropriateCa2microdomain. It remains to be deter-
mined whether this is true in neurohypophyseal terminals.
References
Anderson NG (1998) Co-immunoprecipitation. Identification of interact-
ing proteins. Methods Mol Biol 88:35–45.
Araya R, Liberona JL, Cardenas JC, RiverosN, EstradaM, Powell JA, Carrasco
MA, Jaimovich E (2003) Dihydropyridine receptors as voltage sensors
for a depolarization-evoked, IP3R-mediated, slow calcium signal in skel-
etal muscle cells. J Gen Physiol 121:3–16.
Baldelli P, Hernandez-Guijo JM, Carabelli V, Novara M, Cesetti T, Andres-
Mateos E, Montiel C, Carbone E (2004) Direct and remote modulation
of L-channels in chromaffin cells: distinct actions on alpha1C and
alpha1D subunits? Mol Neurobiol 29:73–96.
Beam KG, Franzini-Armstrong C (1997) Functional and structural ap-
proaches to the study of excitation-contraction coupling. Methods Cell
Biol 52:283–306.
Bean BP (1984) Nitrendipine block of cardiac calcium channels: high-
affinity binding to the inactivated state. Proc Natl Acad Sci USA
81:6388–6392.
Bean BP, Mintz IM (1994) Pharmacology of different types of calcium
channels in rat neurons. In: Handbook inmembrane channels: molecular
and cellular physiology. San Diego: Academic.
Berridge MJ (1998) Neuronal calcium signaling. Neuron 21:13–26.
Bouchard R, Pattarini R, Geiger JD (2003) Presence and functional signifi-
cance of presynaptic ryanodine receptors. Prog Neurobiol 69:391–418.
Carrington WA, Lynch RM, Moore ED, Isenberg G, Fogarty KE, Fay FS
(1995) Superresolution three-dimensional images of fluorescence in
cells with minimal light exposure. Science 268:1483–1487.
Chavis P, Fagni L, Lansman JB, Bockaert J (1996) Functional coupling be-
tween ryanodine receptors and L-type calcium channels in neurons. Na-
ture 382:719–722.
Collin T, Marty A, Llano I (2005) Presynaptic calcium stores and synaptic
transmission. Curr Opin Neurobiol 15:275–281.
Coronado R, Ahern CA, Sheridan DC, Cheng W, Carbonneau L, Bhatta-
charya D (2004) Functional equivalence of dihydropyridine receptor
alpha1S and beta1a subunits in triggering excitation-contraction cou-
pling in skeletal muscle. Biol Res 37:565–575.
De Crescenzo V, ZhuGe R, Velazquez-Marrero C, Lifshitz LM, Custer E,
Carmichael J, Lai FA, Tuft RA, Fogarty KE, Lemos JR, Walsh JVJ (2004)
Ca2 syntillas, miniature Ca2 release events in terminals of hypotha-
lamic neurons, are increased in frequency by depolarization in the ab-
sence of Ca2 influx. J Neurosci 24:1226–1235.
del Valle-Rodriguez A, Lopez-Barneo J, Urena J (2003) Ca2 channel-
sarcoplasmic reticulum coupling: a mechanism of arterial myocyte con-
traction without Ca2 influx. EMBO J 22:4337–4345.
Emptage NJ, Reid CA, Fine A (2001) Calcium stores in hippocampal synap-
tic boutonsmediate short-termplasticity, store-operatedCa2 entry, and
spontaneous transmitter release. Neuron 29:197–208.
Fisher TE, Carrion-Vazquez M, Fernandez JM (2000) Intracellular Ca2
channel immunoreactivity in neuroendocrine axon terminals. FEBS Lett
482:131–138.
Fletcher S, Bowden SE, Marrion NV (2003) False interaction of syntaxin 1A
with a Ca2-activated K channel revealed by co-immunoprecipitation
and pull-down assays: implications for identification of protein-protein
interactions. Neuropharmacology 44:817–827.
Giannini G, Conti A, Mammarella S, Scrobogna M, Sorrentino V (1995)
The ryanodine receptor/calcium channel genes are widely and differen-
tially expressed in murine brain and peripheral tissues. J Cell Biol
128:893–904.
Haller M, Heinemann C, Chow RH, Heidelberger R, Neher E (1998) Com-
parison of secretory responses asmeasured bymembrane capacitance and
by amperometry. Biophys J 74:2100–2113.
Klein MG, Cheng H, Santana LF, Jiang YH, Lederer WJ, Schneider MF
(1996) Twomechanisms of quantized calcium release in skeletal muscle.
Nature 379:455–458.
Lauri SE, Bortolotto ZA, Nistico R, Bleakman D, Ornstein PL, Lodge D, Isaac
JT, Collingridge GL (2003) A role for Ca2 stores in kainate receptor-
dependent synaptic facilitation and LTP at mossy fiber synapses in the
hippocampus. Neuron 39:327–341.
Lemos JR, Nowycky MC (1989) Two types of calcium channels coexist in
peptide-releasing vertebrate nerve terminals. Neuron 2:1419–1426.
Llano I, Gonzalez J, Caputo C, Lai FA, Blayney LM, Tan YP, Marty A (2000)
Presynaptic calcium stores underlie large-amplitudeminiature IPSCs and
spontaneous calcium transients. Nat Neurosci 3:1256–1265.
McDonough SI, Mori Y, Bean BP (2005) FPL 64176modification of CaV1.2
L-type calcium channels: dissociation of effects on ionic current and gat-
ing current. Biophys J 88:211–223.
Melamed-Book N, Kachalsky SG, Kaiserman I, Rahamimoff R (1999) Neu-
ronal calcium sparks and intracellular calcium“noise.” ProcNatl Acad Sci
USA 96:15217–15221.
Mitchell KJ, Lai FA, Rutter GA (2003) Ryanodine receptor type I and nico-
tinic acid adenine dinucleotide phosphate receptorsmediate Ca2 release
from insulin-containing vesicles in living pancreatic beta-cells (MIN6).
J Biol Chem 278:11057–11064.
Mouton J,Marty I, VillazM, Feltz A,Maulet Y (2001) Molecular interaction
of dihydropyridine receptorswith type-1 ryanodine receptors in rat brain.
Biochem J 354:597–603.
Murata Y, Iwasaki H, Sasaki M, Inaba K, Okamura Y (2005) Phosphoinosi-
tide phosphatase activity coupled to an intrinsic voltage sensor. Nature
435:1239–1243.
Mutsuga N, Shahar T, Verbalis JG, Brownstein MJ, Xiang CC, Bonner RF,
Gainer H (2004) Selective gene expression in magnocellular neurons in
rat supraoptic nucleus. J Neurosci 24:7174–7185.
Neher E (1998) Vesicle pools and Ca2 microdomains: new tools for un-
derstanding their roles in neurotransmitter release. Neuron 20:389–399.
Nelson MT, Cheng H, Rubart M, Santana LF, Bonev AD, Knot HJ, Lederer
WJ (1995) Relaxation of arterial smooth muscle by calcium sparks. Sci-
ence 270:633–637.
Ouardouz M, Nikolaeva MA, Coderre E, Zamponi GW, McRory JE, Trapp
BD, Yin X, Wang W, Woulfe J, Stys PK (2003) Depolarization-induced
Ca2 release in ischemic spinal cord white matter involves L-type Ca2
channel activation of ryanodine receptors. Neuron 40:53–63.
Proenza C, O’Brien J, Nakai J, Mukherjee S, Allen PD, Beam KG (2002)
Identification of a region of RyR1 that participates in allosteric coupling
with the 1S (CaV1.1) II-III loop. J Biol Chem 227:6530–6535.
Ransom BR, Brown AM (2003) Intracellular Ca2 release and ischemic
axon injury: the Trojan horse is back. Neuron 40:2–4.
Rios E, Brum G (1987) Involvement of dihydropyridine receptors in
excitation-contraction coupling in skeletal muscle. Nature 325:717–720.
Rios E, Karhanek M, Ma J, Gonzalez A (1993) An allosteric model of the
molecular interactions of excitation-contraction coupling in skeletal
muscle. J Gen Physiol 102:449–481.
Schwartz LM,McCleskey EW, AlmersW (1985) Dihydropyridine receptors
in muscle are voltage-dependent but most are not functional calcium
channels. Nature 314:747–751.
Scriven DR, Klimek A, Asghari P, Bellve K, Moore ED (2005) Caveolin-3 is
adjacent to a group of extradyadic ryanodine receptors. Biophys J
89:1893–1901.
Sharma G, Vijayaraghavan S (2003) Modulation of presynaptic store cal-
cium induces release of glutamate and postsynaptic firing. Neuron
38:929–939.
Shirokova N, Gonzalez A, Ma J, Shirokov R, Rios E (1995) Properties and
roles of an intramembranous charge mobilized at high voltages in frog
skeletal muscle. J Physiol (Lond) 486:385–400.
SunXP, Callamaras N,Marchant JS, Parker I (1998) A continuumof InsP3-
mediated elementary Ca2 signalling events inXenopus oocytes. J Physiol
(Lond) 509:67–80.
De Crescenzo et al. • VICaR in Nerve Terminals J. Neurosci., July 19, 2006 • 26(29):7565–7574 • 7573
Suzuki S, Osanai M, Murase M, Suzuki N, Ito K, Shirasaki T, Narita K,
Ohnuma K, Kuba K, Kijima H (2000) Ca2 dynamics at the frog motor
nerve terminal. Pflu¨gers Arch 440:351–365.
Takahashi Y, Jeong SY, Ogata K, Goto J, Hashida H, Isahara K, Uchiyama Y,
Kanazawa I (2003) Human skeletal muscle calcium channel alpha1S is
expressed in the basal ganglia: distinctive expression pattern among
L-type Ca2 channels. Neurosci Res 45:129–137.
Tarroni P, Rossi D, Conti A, Sorrentino V (1997) Expression of the ryano-
dine receptor type 3 calcium release channel during development and
differentiation of mammalian skeletal muscle cells. J Biol Chem
272:19808–19813.
Tunwell RE, Wickenden C, Bertrand BM, Shevchenko VI, Walsh MB, Allen
PD, Lai FA (1996) The human cardiac muscle ryanodine receptor-
calcium release channel: identification, primary structure and topological
analysis. Biochem J 318:477–487.
Unni VK, Zakharenko SS, Zablow L, DeCostanzo AJ, Siegelbaum SA (2004)
Calcium release from presynaptic ryanodine-sensitive stores is required
for long-term depression at hippocampal CA3–CA3 pyramidal neuron
synapses. J Neurosci 24:9612–9622.
Wang G, Thorn P, Lemos JR (1992) A novel large-conductance Ca2-
activated potassium channel and current in nerve terminals of the rat
neurohypophysis. J Physiol (Lond) 457:47–74.
Wang G, Dayanithi G, Kim S, Hom D, Nadasdi L, Kristipati R, Ramachand-
ran J, Stuenkel EL, Nordmann JJ, Newcomb R, Lemos JR (1997) Role of
Q-type Ca2 channels in vasopressin secretion from neurohypophysial
terminals of the rat. J Physiol (Lond) 502:351–363.
Wang G, Dayanithi G, Newcomb R, Lemos JR (1999) An R-type Ca2 cur-
rent in neurohypophysial terminals preferentially regulates oxytocin se-
cretion. J Neurosci 19:9235–9241.
ZhuGe R, Tuft RA, Fogarty KE, Bellve K, Fay FS, Walsh Jr JV (1999) The
influence of sarcoplasmic reticulum Ca2 concentration on Ca2 sparks
and spontaneous transient outward currents in single smooth muscle
cells. J Gen Physiol 113:215–228.
ZhuGe R, Fogarty KE, Tuft RA, Lifshitz LM, Sayar K, Walsh Jr JV (2000)
Dynamics of signaling between Ca2 sparks and Ca2- activated K
channels studiedwith a novel image-basedmethod for direct intracellular
measurement of ryanodine receptor Ca2 current. J Gen Physiol
116:845–864.
ZhuGe R, DeCrescenzo V, Sorrentino V, Lai FA, Tuft RA, Lifshitz LM, Lemos
JR, Smith C, Fogarty KE,Walsh JV (2006) Syntillas release Ca2 at a site
different from the microdomain where exocytosis occurs in mouse chro-
maffin cells. Biophys J 90:2027–2037.
Zissimopoulos S, Lai FA (2005) Interaction of FKBP12.6 with the cardiac
ryanodine receptor C-terminal domain. J Biol Chem 280:5475–5485.
Zupanc GK, Airey JA, Maler L, Sutko JL, EllismanMH (1992) Immunohis-
tochemical localization of ryanodine binding proteins in the central ner-
vous system of gymnotiform fish. J Comp Neurol 325:135–151.
7574 • J. Neurosci., July 19, 2006 • 26(29):7565–7574 De Crescenzo et al. • VICaR in Nerve Terminals
